Elanco Animal Health Incorporated
ELAN
$21.49
-$0.03-0.14%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 36.00M | 434.00M | 373.00M | 338.00M | 205.00M |
| Total Depreciation and Amortization | 605.00M | 597.00M | 588.00M | 592.00M | 585.00M |
| Total Amortization of Deferred Charges | 65.00M | 67.00M | 69.00M | 70.00M | 84.00M |
| Total Other Non-Cash Items | -7.00M | -645.00M | -584.00M | -608.00M | -592.00M |
| Change in Net Operating Assets | -70.00M | 119.00M | 89.00M | 149.00M | 239.00M |
| Cash from Operations | 629.00M | 572.00M | 535.00M | 541.00M | 521.00M |
| Capital Expenditure | -261.00M | -211.00M | -188.00M | -147.00M | -141.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -36.00M | -36.00M | -36.00M | -36.00M | 0.00 |
| Divestitures | 9.00M | 1.30B | 1.30B | 1.36B | 1.36B |
| Other Investing Activities | -17.00M | -16.00M | -16.00M | -19.00M | -6.00M |
| Cash from Investing | -305.00M | 1.04B | 1.06B | 1.16B | 1.21B |
| Total Debt Issued | 250.00M | 600.00M | 720.00M | 570.00M | 570.00M |
| Total Debt Repaid | -850.00M | -2.34B | -2.11B | -2.05B | -2.15B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 311.00M | 268.00M | -23.00M | -17.00M | -23.00M |
| Cash from Financing | -289.00M | -1.48B | -1.41B | -1.49B | -1.60B |
| Foreign Exchange rate Adjustments | -20.00M | -13.00M | -43.00M | -91.00M | -14.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.00M | 123.00M | 142.00M | 116.00M | 121.00M |